首页|期刊导航|检验医学与临床|血清微管解聚蛋白、CHI3L1与非小细胞肺癌患者肺癌根治术后复发转移的关系

血清微管解聚蛋白、CHI3L1与非小细胞肺癌患者肺癌根治术后复发转移的关系OACSTPCD

Relationship between serum microtubule depolymerizing protein,CHI3L1 and recurrence and metastasis in patients with non-small cell lung cancer after radical lung cancer surgery

中文摘要英文摘要

目的 探讨血清微管解聚蛋白、壳多糖酶3样蛋白1(CHI3L1)与非小细胞肺癌(NSCLC)患者肺癌根治术后复发转移的关系.方法 选取2017年1月至2020年1月在延安大学咸阳医院进行肺癌根治术的153例NSCLC患者作为研究对象,采用酶联免疫吸附试验检测患者术前血清微管解聚蛋白、CHI3L1水平,术后随访3年,根据NSCLC患者肺癌根治术后复发转移情况分为复发转移组和未复发转移组.比较两组一般资料及血清微管解聚蛋白、CHI3L1水平.采用多因素Logistic回归分析NSCLC患者肺癌根治术后复发转移的影响因素.绘制受试者工作特征曲线分析血清微管解聚蛋白、CHI3L1对NSCLC患者肺癌根治术后复发转移的预测价值.结果 153例患者中,49例患者复发转移,纳入复发转移组;104例患者未发生复发转移,纳入未复发转移组.复发转移组肿瘤最大径≥5 cm患者比例、TNM分期为ⅢA期患者比例、分化程度为低分化患者比例、有淋巴结转移患者比例、术后无辅助化疗患者比例、糖类抗原125水平、血清微管解聚蛋白水平、血清CHI3L1水平均高于未复发转移组,差异均有统计学意义(P<0.05).多因素Logistic回归分析结果显示,TNM分期为ⅢA期、有淋巴结转移、血清微管解聚蛋白水平升高及血清CHI3L1水平升高是NSCLC患者肺癌根治术后复发转移的独立危险因素(P<0.05).血清微管解聚蛋白、CHI3L1及2项指标联合检测预测NSCLC患者肺癌根治术后复发转移的曲线下面积分别为0.841、0.763和0.918,2项指标联合检测的预测价值优于2项指标单独检测(P<0.05).结论 血清微管解聚蛋白、CHI3L1水平升高均为NSCLC患者肺癌根治术后复发转移的独立危险因素,2项指标联合检测对NSCLC患者肺癌根治术后复发转移具有较高的预测价值.

Objective To investigate the relationship between serum microtubule depolymerization protein and chitinase 3-like protein 1(CHI3L1)and recurrence and metastasis in patients with non-small cell lung cancer(NSCLC)after radical lung cancer surgery.Methods A total of 153 patients with NSCLC who under-went radical lung cancer surgery of lung cancer in Xianyang Hospital of Yan'an University from January 2017 to January 2020 were selected as the research objects.Enzyme-linked immunosorbent assay was used to detect the serum levels of microtubule disintegrin and CHI3L1 before surgery.According to the recurrence and me-tastasis of NSCLC patients after radical lung cancer surgery,they were divided into recurrence and metastasis group and non-recurrence and metastasis group.The general data and serum levels of microtubule depolymer-ization protein and CHI3L1 were compared between the two groups.Multivariate Logistic regression was used to analyze the influencing factors of recurrence and metastasis in NSCLC patients after radical lung cancer sur-gery.The receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of serum microtubule depolymerization protein and CHI3L1 for postoperative recurrence and metastasis in NSCLC pa-tients after radical lung cancer surgery.Results Among the 153 patients,49 patients had recurrence and me-tastasis they were included in the recurrence and metastasis group,and 104 patients did not have recurrence and metastasis,and were included in the non-recurrence and metastasis group.The proportion of patients with maximum diameter of tumor≥5 cm,TNM stage ⅢA,low differentiation,lymph node metastasis,non postop-erative adjuvant chemotherapy,CA125 level,serum microtubule depolymerization protein level,and serum CHI3L1 level in the recurrence and metastasis group were higher than those in the non-recurrence and metas-tasis group,and the differences were statistically significant(P<0.05).Multivariate Logistic regression anal-ysis showed that TNM stage ⅢA,lymph node metastasis,elevated serum levels of microtubule depolymeriza-tion protein and CHI3L1 were independent risk factors for recurrence and metastasis of NSCLC patients after radical lung cancer surgery(P<0.05).The area under the curve of serum microtubule depolymerization pro-tein,CHI3L1 and their combination for predicting recurrence and metastasis of NSCLC patients after radical lung cancer surgery were 0.841,0.763 and 0.918 respectively.The predictive value of combined detection of the two indicators was better than that of the two indicators alone(P<0.05).Conclusion Elevated serum microtubule depolymerization protein and CHI3L1 levels are both independent risk factors for recurrence and metastasis of NSCLC patients after radical lung cancer surgery.The combined detection of the two indicators has a high predictive value for recurrence and metastasis of NSCLC patients after radical lung cancer surgery.

严洁;王裕虎

延安大学咸阳医院检验科,陕西咸阳 712000陕西省咸阳市第一人民医院胸外科,陕西咸阳 712000

临床医学

非小细胞肺癌微管解聚蛋白壳多糖酶3样蛋白1肺癌根治术复发转移预测价值

non-small cell lung cancermicrotubule depolymerization proteinchitinase 3-like protein 1radical lung cancer surgeryrecurrence and metastasispredictive value

《检验医学与临床》 2024 (008)

1054-1058 / 5

陕西省卫生健康委员会2022年度卫生健康科研项目(2022D0039).

10.3969/j.issn.1672-9455.2024.08.007

评论